192 related articles for article (PubMed ID: 37821528)
1. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract][Full Text] [Related]
2. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.
Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM
Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
Chen Y; Shang H; Zhang S; Zhang X
J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269
[TBL] [Abstract][Full Text] [Related]
5. Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma.
Fang H; Zhang Y; Lin C; Sun Z; Wen W; Sheng H; Lin J
Front Immunol; 2023; 14():1227143. PubMed ID: 37593739
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk.
D'Asti E; Kool M; Pfister SM; Rak J
J Thromb Haemost; 2014 Nov; 12(11):1838-49. PubMed ID: 25163932
[TBL] [Abstract][Full Text] [Related]
7. CTGF expression is indicative of better survival rates in patients with medulloblastoma.
Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG
Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
9. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
[TBL] [Abstract][Full Text] [Related]
10. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
12. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GPR137 suppresses proliferation of medulloblastoma cells in vitro.
Wang C; Liang Q; Chen G; Jing J; Wang S
Biotechnol Appl Biochem; 2015; 62(6):868-73. PubMed ID: 25524330
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211.
Xu D; Chi G; Zhao C; Li D
Cell Physiol Biochem; 2018; 49(5):2012-2021. PubMed ID: 30244244
[TBL] [Abstract][Full Text] [Related]
15. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R
PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271
[TBL] [Abstract][Full Text] [Related]
18. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
[TBL] [Abstract][Full Text] [Related]
19. Combination of PARP and WEE1 inhibitors
Lukoseviciute M; Theodosopoulou A; Holzhauser S; Dalianis T; Kostopoulou ON
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144508
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
